Publications

Vater ST, Velazquez SF, Cogliano VJ. 1995. A case study of cancer data set combinations for PCBs. Regul Toxicol Pharmacol 22:2–10.

Prioleau C, Montague DM, Choksi NY, Southerland SB, Lawler CP, Mailman RB. Unusual neurochemical properties of the novel antipsychotic OPC-14597 in rat striatum. Poster presented at Society for Neuroscience Annual Meeting, 1995.

Covington TR, Gearhart JM, Clewell HJ. A physiologically based pharmacokinetic (PBPK) model for 133Xe and 222Rn in the human. Poster presented at the Society of Toxicology Annual Meeting, Baltimore, MD, March 1995.

Haws, L. How Are We Implementing the Combustion Strategy and Indirect Risk Assessment? Presented at the Texas Natural Resource Conservation Commission Hazardous Waste Seminar. October 26-27, 1994. Houston, TX.

Gargas M, Norton R, Harris MA, Paustenbach D, Finley B. 1994. Urinary excretion of chromium following ingestion of chromite ore processing residue in humans: Implications for biomonitoring. Risk Anal 14(6):1019-1024.

Haws, L. Indirect Risk Assessment. Presented at the Sixth Annual Texas Environmental Superconference. August 4-5, 1994. Austin, TX.

Haws LC, Jackson BA, Turnbull D, and Dressler WE. 1994. Two approaches for assessing human cancer risk from disperse blue 1. Reg Toxicol Pharmacol. 19:80-96.

Haws, L. Overview of TNRCC/EPA Concerns, Strategies, and Schedules Concerning Indirect Risk Assessment Requirements. Presented at the Workshop on Risk Assessment and Waste Incineration Facilities. June 28, 1994, Houston, TX, and June 29, 1994. Austin, TX.

Haws, L. Indirect Risk Workshop. Panel Discussant. Presented at the RCRA Policy Forum. January 31, 1994. Washington, DC.

Haws, L. Keynote Address. Presented at the DRE Environmental Services Workshop on EPA’s New Policy of Hazardous Waste Combustion. January 21, 1994. Austin, TX.

Rish W. 1994. SEC Initiatives in environmental disclosure: How can environmental liability be estimated? Ohio Environmental Law Letter 4(6):3–4.

Choksi NY, Hussain A, Owens CE, Myers AM, Harvey RD, Baldessarini RJ, Wyrick SD, Booth RG. Adenosine A2 and PAT- σ3 agonists affect adenylyl cyclase activity and dopamine synthesis. Poster presented at North Carolina Society for Neuroscience Meeting, 1994.

Choksi NY, Hussain A, Myers AM, Owens CE, Harvey RD, Wyrick SD, Baldessarini RJ, Booth RG. Stimulation of brain cAMP and dopamine synthesis by adenosine A2 and σ3 agonists. Poster presented at Society for Neuroscience Annual Meeting, 1994

Sahl JD, Kelsh MA, Smith RW, Aseltine DA. 1994. Exposure to 60 Hz magnetic fields in the electric utility work environment. Bioelectromagnetics 15(1):21-32. https://doi.org/10.1002/bem.2250150107

Haws, L. Principles of Toxicology and Risk Assessment. Presented at the University of Texas at Austin. LBJ School of Public Affairs. September 10, 1993. Austin, TX.

Copeland TL, Paustenbach DJ, Harris MA, and Otani J. 1993. Comparing the results of a Monte Carlo analysis with EPA’s reasonable maximum exposed individual (RMEI): a case study of a former wood treatment site. Reg Toxicol Pharmacol. 18:275-312.

Harris, MA, Zacharewski T, and Safe S. 1993. Comparative potencies of Aroclors 1232, 1248, 1254, and 1260 in male wistar rats—Assessment of the toxic equivalency factor (TEF) approach for polychlorinated biphenyls (PCBs). Fund Appl Toxicol. 20:456-463.

Steup DR, Hall P, McMillan DA, Sipes IG. 1993. Time course of hepatic injury and recovery following coadministration of carbon tetrachloride and trichloroethylene in Fischer-344 rats. Toxicol Pathol 21:327–334.

Vater ST, McGinnis PM, Schoeny RS, Velazquez SF. 1993. Biological considerations for combining carcinogenicity data for quantitative risk assessment. Regul Toxicol Pharmacol 18(3):403–418.

Sahl JD, Kelsh MA, Greenland S. 1993. Cohort and nested case-control studies of hematopoietic cancers and brain cancer among electric utility workers. Epidemiology 4(2):104-114. https://doi.org/10.1097/00001648-199303000-00005